These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36851628)

  • 1. Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses.
    Ogorek TJ; Golden JE
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding host responses to equine encephalitis virus infection: implications for therapeutic development.
    Kehn-Hall K; Bradfute SB
    Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1551-1566. PubMed ID: 36305549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
    Fierro C; Weidenthaler H; Vidojkovic S; Schmidt D; Gafoor Z; Stroukova D; Zwiers S; Müller J; Volkmann A
    Vaccine; 2024 Apr; 42(10):2695-2706. PubMed ID: 38494412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses.
    Boghdeh NA; McGraw B; Barrera MD; Anderson C; Baha H; Risner KH; Ogungbe IV; Alem F; Narayanan A
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
    Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
    J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
    Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequelae and Animal Modeling of Encephalitic Alphavirus Infections.
    Reyna RA; Weaver SC
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
    Coates EE; Edupuganti S; Chen GL; Happe M; Strom L; Widge A; Florez MB; Cox JH; Gordon I; Plummer S; Ola A; Yamshchikov G; Andrews C; Curate-Ingram S; Morgan P; Nagar S; Collins MH; Bray A; Nguyen T; Stein J; Case CL; Kaltovich F; Wycuff D; Liang CJ; Carlton K; Vazquez S; Mascola JR; Ledgerwood JE;
    Lancet Infect Dis; 2022 Aug; 22(8):1210-1220. PubMed ID: 35568049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alphaviral equine encephalomyelitis (Eastern, Western and Venezuelan).
    Aréchiga-Ceballos N; Aguilar-Setién A
    Rev Sci Tech; 2015 Aug; 34(2):491-501. PubMed ID: 26601451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
    Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
    Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
    Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
    J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a brain-penetrant antiviral in lethal Venezuelan and eastern equine encephalitis mouse models.
    Cao X; Yang D; Parvathareddy J; Chu YK; Kim EJ; Fitz-Henley JN; Li X; Lukka PB; Parmar KR; Temrikar ZH; Dhole P; Adcock RS; Gabbard J; Bansal S; Lee J; Zalduondo L; Hayes E; Stabenow J; Meibohm B; Fitzpatrick EA; Bailey K; Campos RK; Julander JG; Rossi SL; Chung D; Jonsson CB; Golden JE
    Sci Transl Med; 2023 Apr; 15(691):eabl9344. PubMed ID: 37043558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.
    Lundberg L; Brahms A; Hooper I; Carey B; Lin SC; Dahal B; Narayanan A; Kehn-Hall K
    Antiviral Res; 2018 Sep; 157():57-67. PubMed ID: 29981794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological Sequelae Resulting from Encephalitic Alphavirus Infection.
    Ronca SE; Dineley KT; Paessler S
    Front Microbiol; 2016; 7():959. PubMed ID: 27379085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New World alphavirus protein interactomes from a therapeutic perspective.
    Carey BD; Bakovic A; Callahan V; Narayanan A; Kehn-Hall K
    Antiviral Res; 2019 Mar; 163():125-139. PubMed ID: 30695702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.